Dealagdon, Edgar D.

HRN: 29-14-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/19/2026
06/26/2026
IV
2.25gm
Q8h
Non Healing Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines